Bapcor Ltd (ASX: BAP) was one of the ASX companies that reported its FY2021 earnings numbers to the markets yesterday.

The Bapcor share price didn’t exactly react the way investors might have hoped, with the auto parts company’s shares falling 4.56% by yesterday’s close. Today, the selling has continued, with Bapcor shares down another 1.36% at the time of writing to $7.595 a share.

There were many interesting tidbits in yesterday’s earnings, which my Fool colleague James covered yesterday. In summary, Bapcor delivered a revenue increase of 20.4% to $1.76 billion, a 28.8% bump in pro forma earnings before interest, tax, depreciation and amortisation (EBITDA), and a 46.5% rise in pro forma net profit after tax to $130.1 million.

The company also increased its final dividend to 11 cents per share, fully franked. That means Bapcor will pay a total dividend of 20 cents per share for the full year, which is up 14.3% year on year.

Bapcor’s dividend puts company on a good path

This latest dividend continues the path Bapcor has been on for a few years now. This company has now managed to raise its annual dividend every single year since 2015. Back then, Bapcor paid out an interim dividend of 4 cents per share in April, as well as a final dividend of 4.7 cents per share in September.

In contrast, 2021 has seen Bapcor pay an interim dividend of 9 cents per share in March already. And we now know that investors will receive their second 2021 dividend of 11 cents per share on 14 September.

That dividend growth rate represents a compounded annual growth rate of 14.88% since 2015 for Bapcor.

And since the company told us yesterday that it earned 38.3 cents in pro forma earnings per share (EPS) for FY21, we can place this dividend at an earnings payout ratio of 52.2%.

Since Bapcor managed to grow its EPS by 26.8%, but its full-year dividends by ‘only’ 14.3%, this means that Bapcor has managed to raise its dividend and lower its payout ratio at the same time. That’s often good news for future dividend payments.

About the company’s share price

Bapcor shares are, on today’s pricing, up a solid 10.36% over the past 12 months. However, year to date, the story is a little different. Bapcor remains down 2.62% in 2021 so far, vastly underperforming the broader S&P/ASX 200 Index (ASX: XJO), which is up 11.3% over the same period.

Over the past 5 years, Bapcor shares have appreciated by 19.54%, against the ASX 200’s 34.6%.

At the current Bapcor share price, the company has a market capitalisation of $2.59 billion, and a price-to-earnings (P/E) ratio of 24.55. Bapcor’s trailing dividend yield presently stands at 2.43%.

The post The Bapcor (ASX:BAP) dividend bumps up 14% appeared first on The Motley Fool Australia.

More reading

• ASX 200 midday update: Treasury Wine results, Origin’s $2bn loss, Star impresses
• These top ASX dividend shares keep giving investors a payrise
• 2 ASX sectors to avoid like the plague
• 5 things to watch on the ASX 200 on Thursday
• Which shares topped ASX 200 (ASX:XJO) trading volumes on Wednesday

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bapcor. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3gcLO4w

The NRW Holdings Limited (ASX: NWH) share price is soaring after the company released its results for the financial year 2021 (FY21).

Right now, the NRW Holdings share price is trading at $1.88, 13.3% higher than its closing price yesterday.

NRW share price jumps on $2.3 billion revenue

Here’s how the diversified contracting service provider performed during FY21:

• $2.3 billion in revenue – 11.5% more than in FY20
• Earnings before interest, tax, depreciation, and amortisation (EBITDA) of $266.7 million. That’s 6.7% higher than the prior comparable period
• 5-cent fully franked final dividend.

Of the company’s approximately $2.3 billion of revenue, its civil works segment brought in $726.5 million, mining brought in around $1.177 billion, and minerals, energy, and technologies earned $426.9 million.

NRW’s operating earnings before interest and tax came in at $120.6 million. That’s lower than it was in FY20, mainly due to high staff turnover, labour rate increases, and skill shortages in Western Australia’s Pilbara region.

NRW ended the period with $163.9 million of cash and $196.7 million of debt.

What happened in FY21 for NRW Holdings?

It was a busy financial year for NRW Holdings and its share price.

The company acquired Primero Group Ltd in March.

It also developed and installed pit crushing and conveying solutions to reduce its carbon emissions by at least 75% when compared to traditional mining and haul solutions.

Unfortunately, COVID-19 impacted the company’s staff retention, with staff turnover reaching record highs.  

Border restrictions still mean interstate worker numbers are far below pre-pandemic levels. NRW historically sees 30% of its workforce coming from Australia’s east coast.

What did management say?

NRW Holdings’ managing director and CEO Jules Pemberton commented on the results, saying:

The COVID-19 pandemic has had a significant impact on the business throughout the financial year…

Resource availability and labour cost pressures impacted WA Pilbara project completion costs and schedules. Both these issues were attributed to COVID-19 measures including border closures which limited the available workforce.

Most of those projects however were complete at 30 June 2021, other than resolution of claims and contract variations. Whilst these projects have had the most impact on our financial performance, it is important to note that large parts of our business have performed to expectations.

What’s next for NRW Holdings?

Here’s what may drive the NRW Holdings share price in FY22.

The company is forecasting its revenue for FY22 will be between $2.4 billion and $2.5 billion. $2 billion of its expected revenue is already either in NRW’s order book, supported by a letter of intent, or is expected to be reoccurring.

NRW anticipates its operating EBIT for FY22 will be between $145 million and $155 million.

Additionally, the company’s order book is expected to grow by $1 billion to $4.4 billion in FY22 after NRW received a letter of intent for the extension of mining services at Curragh.

Additionally, NRW is preparing its first sustainability report. It will be published in September.

NRW Holdings share price snapshot

The NRW share price has slipped 37% year to date. It is also 9% lower than it was this time last year.

The post NRW Holdings (ASX:NWH) share price soars 13% on FY21 earnings appeared first on The Motley Fool Australia.

More reading

• Humm (ASX:HUM) share price higher on FY21 results
• ASX 200 midday update: Treasury Wine results, Origin’s $2bn loss, Star impresses
• Afterpay (ASX:APT) share price edges higher as ‘Afterpay Day’ kicks off
• Accent (ASX:AX1) share price slides despite strong sales growth
• Origin (ASX:ORG) share price slides 5% after revenue decline

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3yZkhuX

The ASX Ltd (ASX: ASX) share price has eked out a small gain of 0.54% to $82.08 following the release of the company’s full year FY21 results.

ASX share price tips higher on mixed results

ASX delivered a mixed result in light of record levels of retail trading from last year and the effects of the RBA’s current policy settings. Key highlights include:

• Operating revenue of $951.5 million, up 1.4% on FY20
• Underlying net profit after tax (NPAT) of $480.9 million, down 6.4%
• Total expenses of $310.3 million, up 8.4%
• Underlying earnings per share of 248.4 cents, down 6.4%
• Final dividend per share of 111.2 cents per share, down 9.2%

What happened in FY21 for ASX?

The ASX’s listings and issuer services made a strong contribution to growth, with revenue increasing 8.9% to $258.2 million. The company was pleased to highlight 176 new listings with a combined market cap of new listings of $40.6 billion, up a respective 112% and 50.5% against the prior corresponding period. Although, the market for secondary capital raisings was down 11.8% to $61.9 billion given the comparative strength of 2H20 activity.

The strong result from listings and issuer services was offset by a weaker performance from the company’s derivatives and OTC markets segment. This segment experienced a 10.4% decline in revenue to $284.6 million, reflecting a decline in futures volume and low-interest rates.

ASX’s trading services delivered a solid result in light of record trading volumes in 2H20. The “solid performance in retail activity” translated to a 3.4% increase in revenue to $265 million.

Finally, the company’s equity post-trade services experienced a 12.8% increase in revenue to $143.7 million, driven by strong growth in trading and settlement activity.

It appears that the market is relatively pleased with the mixed result, with the ASX share price pushing 1.04% higher to $82.49.

A slight concern could be the 8.4% increase in expenses. However, the company advised that this increase reflects the growth in full-time employees as a result of the timing of FY20 hires and new roles to support the company’s growth initiatives.

The ASX elected to pay a final dividend of 112.4 cents per share, reflecting a payout ratio of 90% of underlying profit. This brings the company’s FY21 dividend to 223.6 cents per share or a yield of 2.7% at today’s prices.

Management commentary

ASX managing director and CEO Dominic Stevens commented on the result, saying:

ASX has delivered a resilient result overall in FY21, with operating revenue growing 1.4% to $951.5 million, up $13.1 million, following a very robust FY20. Strong listings and equity market activity, due in part to an ongoing surge in retail trading, were tempered by the effects of the RBA’s current policy settings on both short-end futures volumes and interest income. This led to a 3.6% fall in statutory profit to $480.9 million – down $17.7 million

Looking ahead at FY22, Stevens said:

FY22 has continued where FY21 left off. Equities trading remains robust given ongoing uncertainty
generated by COVID and the listings pipeline looks healthy. While futures volumes remain linked to the
RBA’s policy settings, market support for our suite of energy derivatives and for Austraclear activity looks
positive.

What’s next for ASX?

The typically slow moving ASX share price has had a solid performance in 2021, up 13% year-to-date.

The company provided solid outlook commentary citing equities trading is likely to remain robust due to COVID-19 related uncertainty and geopolitical issues. In addition to a well-supported pipeline of listings and settlements to benefit from fiscal stimulus and strong mortgage issuance.

ASX expects FY22 expenses to increase 5-7% alongside capital expenditure guidance between $105 million to $115 million.

The post ASX (ASX:ASX) share price edges higher on mixed FY21 results appeared first on The Motley Fool Australia.

More reading

• How did the ASX share price respond last earnings season?
• ASX (ASX:ASX) share price climbs on reports of major restructure
• Leading brokers name 3 ASX shares to buy today

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3k4H0j4

On Wednesday the S&P/ASX 200 Index (ASX: XJO) was out of form again and edged lower. The benchmark index fell 0.1% to 7,502.1points.

Will the market be able to bounce back from this on Thursday? Here are five things to watch:

ASX 200 expected to fall

The Australian share market looks set to fall on Thursday. According to the latest SPI futures, the ASX 200 is expected to open the day 51 points or 0.7% lower this morning. This follows a disappointing night of trade on Wall Street which saw the Dow Jones drop 1.1%, the S&P 500 fall 1.1%, and the Nasdaq tumble 0.9% lower. US markets tumbled after the latest US Federal Reserve meeting minutes gave an insight into its tapering plans.

Treasury Wine full year results

The Treasury Wine Estates Ltd (ASX: TWE) share price will be on watch today when it releases its full year results. This will be the first annual result since the wine company was effectively shut out of China. According to a note out of Goldman Sachs, its analysts expect Treasury Wine to post EBITS of $508.2 million. This compares to its guidance of $495 million to $515 million.

Oil prices sink

Energy producers such as Oil Search Ltd (ASX: OSH) and Woodside Petroleum Limited (ASX: WPL) could have a difficult day after oil prices sank overnight. According to Bloomberg, the WTI crude oil price is down 2.9% to US$64.63 a barrel and the Brent crude oil price has fallen 2.2% to US$67.49 a barrel. Rising COVID-19 cases globally is weighing on the demand outlook.

Gold price flat

Gold miners Evolution Mining Ltd (ASX: EVN) and Regis Resources Limited (ASX: RRL) could have a subdued day after the gold price traded flat. According to CNBC, the spot gold price is steady at US$1,787.7 an ounce. COVID fears were offset by concerns the US Federal Reserve could reduce stimulus next year. Evolution is also due to release its results today.

Origin FY 2021 results

The Origin Energy Ltd (ASX: ORG) share price could be on the move today when it releases its full year results. Goldman Sachs expects revenue of $955 million, which will be the lower end of Origin’s guidance range of $940 million to $1,020 million. Though, it believes the main focus will be on management’s commentary. It expects management to confirm that Energy Markets have troughed and should steadily rebuild from FY 2023.

The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

More reading

• Why the Woodside (ASX:WPL) dividend jumped by 14%
• Treasury Wine (ASX:TWE) share price on watch after FY21 earnings beat
• 2 ASX sectors to avoid like the plague
• Which shares topped ASX 200 (ASX:XJO) trading volumes on Wednesday
• ASX 200 drops, BHP falls, Pro Medicus soars

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Treasury Wine Estates Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/381mxWt

If you would like to bolster your portfolio with some blue chips, then you might want to take a look at these ASX shares.

Here’s why these two blue chip ASX shares are highly rated:

ResMed Inc. (ASX: RMD)

The first blue chip ASX share for investors to consider is ResMed. It is a medical device company with a focus on sleep disorders. It has been a real standout performer over the last decade thanks to its industry leading products and the growing awareness and prevalence of sleep disorders.

The good news is that the company still has a very long runway for growth and has recently bolstered its portfolio with the launch of its AirSense 11 product. This comes at a time when one of its main rivals is busy recalling and fixing millions of competing devices and trying to repair its reputation.

Morgans is positive on the company and currently has an add rating and $41.34 price target on its shares.

SEEK Limited (ASX: SEK)

Another blue chip share to look at is SEEK. It is the leading job listings company in the ANZ region and has a number of growing businesses around the globe.

During the first half of FY 2021, SEEK was dominating the local market and averaging 35 million monthly visits and 160,000 active hirers. This led to the company having almost a third of all placements in the region, which is five times greater than its nearest rival.

This has put the company in a great position to benefit from Australia’s recovery from the pandemic. With unemployment levels tipped to fall materially, job ad volumes look set to increase significantly once the economy opens up again.

Macquarie is very positive on SEEK and has an outperform rating and $40.00 price target on its shares.

The post 2 top blue chip ASX shares rated as buys appeared first on The Motley Fool Australia.

More reading

• Why Domain, Money3, ResMed, & Steadfast shares are charging higher
• ResMed (ASX:RMD) share price hits record high on new product release
• Seek (ASX:SEK) share price slides after growth fund spin off
• 2 excellent ASX 200 blue chip shares named as buys
• Leading brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. and SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2W5Q6nn

The Pro Medicus Limited (ASX: PME) share price was the standout performer on the S&P/ASX 200 Index (ASX: XJO) on Thursday.

The healthcare technology company’s shares were up as much as 16.5% to a record high of $65.90 before finishing the day up 15.5%.

The Pro Medicus share price is now up 86% since the start of the year.

Why did the Pro Medicus share price rocket higher?

Investors were bidding the Pro Medicus share price higher following the release of an impressive full year result this morning.

For the 12 months ended 30 June, the company reported a 19.5% increase in revenue to $67.9 million and a 43% jump in earnings before interest and tax (EBIT) to $42.7 million.

This was driven by the implementation of a series of major contract wins and further operating leverage.

Also giving the Pro Medicus share price a boost were comments by management. It advised that although FY 2021 was a record year on new contracts, its pipeline remains very healthy in respect to quality and quantity.

How does this compare to expectations?

Although its revenue fell a touch short of the market’s expectation of $70 million, this was largely due to foreign exchange headwinds.

Positively, despite its revenue missing, its EBIT was ahead of the consensus estimate of $41.6 million thanks to stronger than expected margin expansion.

Goldman Sachs has commented on the result. It said: “Group revenue of $67.9m fell -3% short of consensus expectations as revenue growth for the core PACS segment of +18% (to $55.3m) fell short of our expectations of +26% (to $59.0m). However, on a constant currency basis, revenue grew +30% to $74.0m, likely explaining the majority/all of the miss.”

“Furthermore, EBIT grew +43%, coming in +3% ahead of expectations, as margins increased +1,036bps (vs. cons +690bps). Net income grew +34% to $30.9m and period-end cash grew +42% to $61.8m, and the company remains debt-free.”

Is it too late to invest?

Goldman Sachs currently has a neutral rating and $55.60 price target on its shares. This compares to the current Pro Medicus share price of $65.35.

However, it has yet to update its model to reflect this result. So, there’s a chance in the coming days it could lift its price target higher. Investors may want to stay tuned for that one.

The post Pro Medicus (ASX:PME) share price rockets 16% on earnings beat appeared first on The Motley Fool Australia.

More reading

• ASX 200 drops, BHP falls, Pro Medicus soars
• Here are the top 10 ASX 200 shares today
• Passive income your thing? These 3 ASX dividend shares just declared bigger payments
• Which ASX 300 shares are the biggest winners and losers mid-week?
• Why Beach, Domain, Domino’s, & Pro Medicus shares are storming higher

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3xRomQB

The S&P/ASX 200 Index (ASX: XJO) has had a rather flat day of trading this Wednesday. By today’s market close, the ASX 200 had slid 0.12% to 7,502.1 points.

With such an uninteresting move for the index today, let’s instead dive into some of the ASX 200 shares that are experiencing the heaviest trading volumes and see what we can find.

3 ASX 200 shares that topped trading volumes on Wednesday

Scentre Group (ASX: SCG)

ASX real estate investment trust (REIT) Scentre Group is our first ASX 200 share to check out today. This Wednesday has seen a healthy 22.4 million Scentre units swap hands. There’s no real news, announcements or other catalysts we can point to today to explain this move.

However, the Scentre unit price surged a little in afternoon trade. The Scentre share price closed the day up 1.19% to $2.56 a unit. It might be this positive move (in defiance of the ASX 200 too) that sparked a high volume of trading with this company today.

BHP Group Ltd (ASX: BHP)

The ‘Big Australian’ makes the list today with a solid 25.7 million BHP shares changing hands. A top ASX 200 miner, BHP has seen a sharp reaction to the release of its FY21 earnings report after market close yesterday evening.

BHP shares fell sharply on open this morning, and closed the day down a substantial 7.07% to $47.70 at the time of writing. It’s almost certainly this large share price slide that is behind the high volume of BHP shares traded today. Especially considering BHP’s sheer size, as well as the magnitude of today’s share price drop.

Pilbara Minerals Ltd (ASX: PLS)

ASX 200 lithium producer Pilbara, which regularly appears on this list, came in at the top today, with a hefty 38.7 million shares changing hands. Again, there is no real news or developments we can point to here.

But the Pilbara share price has come under a lot of pressure over the past week or so, having lost around 13% since last Wednesday. It has also dropped a nasty 3.18% just today, which is probably the reason why we saw an elevated trading volume.

The post Which shares topped ASX 200 (ASX:XJO) trading volumes on Wednesday appeared first on The Motley Fool Australia.

More reading

• What you need to know about the BHP (ASX:BHP) dividend dates in 2021
• 2 ASX sectors to avoid like the plague
• 5 things to watch on the ASX 200 on Thursday
• ASX 200 drops, BHP falls, Pro Medicus soars
• The ASX reporting wrap-up: BHP Group, Domino’s, CSL

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3mdhKtC

The S&P/ASX 200 Index (ASX: XJO) fell 0.1% to 7,502 points today.

Here are some of the highlights from the ASX:

Pro Medicus Limited (ASX: PME)

The Pro Medicus share price surged 16% today after releasing its FY21 result. It was the best performer in the ASX 200.

It reported a 19.5% increase of revenue to $67.9 million. This led to the earnings before interest and tax (EBIT) margin increasing to 63.2%.

Underlying profit before tax increase 41% to $42.6 million, whilst net profit grew 33.7% to $30.9 million.

The board announced a final fully franked dividend of 8 cents per share, taking the full year dividend to 15 cents per share, up 25%.

During the year, Pro Medicus won a number of contracts during the year, in both Europe and the US.

Pro Medicus CEO Dr Sam Hupert said regarding its outlook:

Although we had a record year in terms of new contracts, our pipeline remains very healthy both in terms of quality and quantity. There is a good mix across the spectrum of opportunities; some cloud, some on-premise, some academic and some in the non-academic IDN space as well as in the for-profit and private sector.

Domino’s Pizza Enterprises Ltd. (ASX: DMP)

The Domino’s share price jumped 7% after releasing its FY21 result.

It reported that network sales increased by 14.6% to $3.74 billion, with online sales rising 21.5% to $2.93 billion.

Total underlying EBIT grew 27.2% to $293 million, with international EBIT rising 41.4% to $199.5 million. The international segment now represents 68.1% of group EBIT. Japan in-particular saw very fast EBIT growth, with EBIT rising 52.8%. EU EBIT rose 48.3%.

Free cashflow surged 40.2% to $216.2 million.

Domino’s has decided to increase its dividend payout ratio to 80%, up from 70%. It is going to pay a final dividend of 85.1 cents per share.

The ASX 200 food business said that it opened 285 new stores (up 10.7%). Its three to five year outlook for new store openings has been increased to growth of between 9% to 12%, up from 7% to 9%.

It also said that it had expanded its debt facilities, at lower margins, to ensure it had sufficient resources for “strategic acquisitions”.

BHP Group Ltd (ASX: BHP)

The huge miner made a number of announcements yesterday. But the BHP share price fell 7% today, making it the worst performer in the ASX 200.

It revealed that its oil business was going to merge with Woodside Petroleum Limited (ASX: WPL). The oil business will benefit from greater scale and growth options.

BHP also said that it was also going to end its dual structure in the UK, with the business shifting entirely to Australia.

In terms of the FY21 result, BHP said that profit from operations rose by 80% to US$25.9 billion. Attributable profit went up by 42% to US$11.3 billion. The attributable profit included an “exceptional loss” of US$5.8 billion largely relating to impairments of potash and energy coal assets. Underlying attributable profit jumped 88% to US$17.08 billion.

The ASX 200 miner’s board announced a full year dividend of US$3.01 per share. Net debt decreased by 66% to US$4.1 billion after net operating cash flow went up 73% to US$27.2 billion.

The post ASX 200 drops, BHP falls, Pro Medicus soars appeared first on The Motley Fool Australia.

More reading

• Why the Woodside (ASX:WPL) dividend jumped by 14%
• What you need to know about the BHP (ASX:BHP) dividend dates in 2021
• Domino’s (ASX:DMP) dividend boosted by 45%
• These top ASX dividend shares keep giving investors a payrise
• 2 ASX sectors to avoid like the plague

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2W3HoWY

On Tuesday the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped notably lower. The benchmark index ended the day 0.95% lower at 7,511 points.

Will the market be able to bounce back from this on Wednesday? Here are five things to watch:

ASX 200 futures pointing lower

The Australian share market is expected to continue its poor run on Wednesday. According to the latest SPI futures, the ASX 200 is expected to open the day 38 points or 0.5% lower today. This follows a poor night of trade on Wall Street, which saw the Dow Jones fall 0.8%, the S&P 500 drop 0.7%, and the Nasdaq sink 0.9%.

BHP reports huge profit growth

The BHP Group Ltd (ASX: BHP) share price will be on watch today following the after market release of its full year results on Tuesday. The Big Australian reported a 69% increase in underlying EBITDA to US$37,379 million, allowing it to declare a record final dividend of US$2.00 per share. This brought its full year dividend to US$3.01 per share, up 151% and ahead of expectations. BHP and Woodside Petroleum Limited (ASX: WPL) also agreed to merge their oil and gas operations. BHP’s UK shares ended the day 3.5% higher.

Oil prices fall

It could be a difficult day for energy producers such as Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) after oil prices fell. According to Bloomberg, the WTI crude oil price is down 0.8% to US$66.76 a barrel and the Brent crude oil price is down 0.5% to US$69.18 a barrel. Weak demand in Asia has been weighing on prices.

CSL full year results

The CSL Limited (ASX: CSL) share price will be on watch today when it releases its full year results. The biotherapeutics company has provided guidance for earnings growth of 3% to 8% in FY 2021. However, this isn’t likely to be the main focus with the result. Investors will be keen to find out how plasma collection headwinds are impacting the company. Goldman recently commented: “We see scope for cautious commentary on FY22, largely predicated around cost, which may manifest in another year of cautious guidance.”

Gold price falls

Gold miners Evolution Mining Ltd (ASX: EVN) and Newcrest Mining Limited (ASX: NCM) could have a subdued day on Wednesday after the gold price edged lower. According to CNBC, the spot gold price is down 0.15% to US$1,787 an ounce. The precious metal was rising on weaker bond yields before giving back these gains.

The post 5 things to watch on the ASX 200 on Wednesday appeared first on The Motley Fool Australia.

More reading

• CSL (ASX:CSL) share price in focus after outperforming FY21 guidance
• How did the Newcrest (ASX: NCM) share price respond last earnings season?
• Woodside (ASX:WPL) announces new leader
• ASX 200 drops, Magellan (ASX:MFG) and Breville (ASX:BRG) sink after FY21 results
• BHP (ASX:BHP) share price on watch after record dividend and Woodside merger deal

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3k2fylT

If you’re interested in gaining exposure to the small side of the market, then you might want to look at the ASX shares listed below.

Here’s why these small cap ASX shares could be ones to watch:

Adore Beauty Group Limited (ASX: ABY)

The first small cap to watch is Adore Beauty. Australia’s leading online beauty retailer has been growing strongly in recent years and particularly during FY 2021. For example, it expects to report full year revenue growth of between 43% and 47% this year. And while FY 2022’s growth will inevitably moderate as it cycles strong sales periods during the pandemic, its longer term outlook remains very positive. This is due to its leadership position online, growing customer base, and the structural shift online for beauty sales.

Bigtincan Holdings Ltd (ASX: BTH)

Another small cap to watch is Bigtincan. It is a provider of enterprise mobility software that allows sales and service organisations to increase their sales win rates, reduce expenditures, and improve customer satisfaction through improved mobile worker productivity. A testament to the quality of its platform is that it has a large number of blue chips as customers. This includes Australia and New Zealand Banking GrpLtd (ASX: ANZ), Cardinal Health, Nike, and Red Bull. Increasing demand has been underpinning strong recurring revenue growth in FY 2021.

Volpara Health Technologies Ltd (ASX: VHT)

A final small cap to watch is Volpara. This healthcare technology company uses artificial intelligence to assist with the early detection of breast cancer. Volpara achieves this by allowing users to analyse mammograms and associated patient data. Volpara is currently generating approximately NZ$27.8 million in annual recurring revenues (ARR). However, this is well short of its addressable market, which management estimates is US$750 million in breast cancer screening alone. This gives the company a significant runway for growth over the next decade.

The post 3 small cap ASX shares to put on your watchlist this week appeared first on The Motley Fool Australia.

More reading

• 3 exciting small cap ASX shares to watch
• 2 exciting ASX tech shares that could be buys
• 3 excellent ASX tech shares
• 2 leading ASX e-commerce shares that could be buys in August 2021
• 2 ASX tech shares rated as buys

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended BIGTINCAN FPO and VOLPARA FPO NZ. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Adore Beauty Group Limited. The Motley Fool Australia owns shares of and has recommended BIGTINCAN FPO and VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3iUJb9e